Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2024
Companies covered: 12
Tables & Figures: 132
Countries covered: 19
Pages: 130
Download Free PDF

Cyclosporine Market
Get a free sample of this reportGet a free sample of this report Cyclosporine Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Cyclosporine Market Size
The global cyclosporine market size was valued at USD 3.3 billion in 2024 and is estimated to grow at a CAGR of 14.5% from 2025 to 2034. In recent years, the sales of cyclosporine have specifically increased due to the growing demand for organ transplantation.
For instance, as per the data published by the National Institute of Health, around 46,632 organ transplants were completed in the year 2020 in the U.S., which reflects a growth of 12.7% from the previous year. Cyclosporine is in high demand in recent years as more and more organ transplant procedures are being performed. Thus, given the key role of cyclosporine in organ transplant patients, the cyclosporin market is anticipated to witness rapid growth in the future years.
Additionally, the growth of cyclosporine market has also been driven by increasing cases of autoimmune disorders such as rheumatoid arthritis. Cyclosporine helps treat the symptoms of arthritis but also decreases the progression of the condition thereby reducing the risk of long-term joint damage and disability. Furthermore, broadened access to health care in emerging countries coupled with an increase in investments in research and development focused on building new types of immunosuppressive therapies, further accelerates market growth.
Cyclosporine is an immunosuppression drug used to prevent organ rejection in transplant patients and has also found use in certain autoimmune disorders. It acts by inhibiting the normal activity of the T-lymphocytes that are central to the immune response. Kidney, liver, and heart transplant recipients are commonly treated with cyclosporine in order to decrease the likelihood of graft rejection.
Cyclosporine Market Trends
The growing prevalence of autoimmune diseases acts as a strong catalyst for the growth of the market.
Cyclosporine Market Analysis
Based on the indication, the global market is segmented into transplant rejection prophylaxis, rheumatoid arthritis, psoriasis, autoimmune myasthenia gravis, dry eye, and other indications. The transplant rejection prophylaxis segment dominated the market and was valued at USD 1.2 billion in 2024.
Based on dosage form, the cyclosporine market is categorized into capsule, eye drops, solutions, and creams and ointments. The capsule segment accounted for the highest market share of 31.8% in 2024.
Based on route of administration, the cyclosporine market is categorized into oral, topical, and parenteral. The oral segment is anticipated to witness high growth to reach USD 5.5 billion by 2034.
Based on distribution channel, the cyclosporine market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is anticipated to grow at a CAGR of 14.2% between 2025 – 2034.
In 2024, the U.S. held a significant position in the North America cyclosporine market and was valued at USD 1.1 billion.
Germany shows strong growth potential in the cyclosporine market.
The cyclosporine market in Asia Pacific is estimated to grow at a CAGR of 15% over the next few years.
India presents significant growth potential in the cyclosporine market.
Brazil cyclosporine market is projected to witness growth in coming years.
Cyclosporine Market Share
The market is very competitive with both global as well as regional and local players operating in the market. Major firms in this market, such as Novartis, AbbVie, and Apotex, hold a dominant market share with their extensive product offerings and strong distribution networks. These firms together have a strong presence in the global market spanning over a hundred countries across the world. They manage to distribute cyclosporin products across both emerging and already developed markets with the help of strong supply chains. Further, these players enhance their market reach with strategic growth initiatives such as partnerships, acquisitions, and distribution agreements.
Additionally, new entrants and other smaller pharmaceutical companies are now coming up with innovative dosages and combination therapies to strengthen their market shares. This is further fueled by increasing cases of autoimmune diseases and organ transplants which motivates the companies to expand their reach. Companies use gaining regulatory approvals and geographic expansion as ways to strategically strengthen their position in this ever-changing market.
Cyclosporine Market Companies
Few of the prominent players operating in the cyclosporine industry include:
USP’s of top players
Cyclosporine Industry News
The cyclosporine market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:
Click here to Buy Section of this Report
Market, By Indication
Market, By Dosage Form
Market, By Route of Administration
Market, By Distribution Channel
The above information is provided for the following regions and countries: